Nolan D - Search Results

1

Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir.

Mallal S, Nolan D, Witt C, Masel G, Martin AM, Moore C, Sayer D, Castley A, Mamotte C, Maxwell D, James I, Christiansen FT. Mallal S, et al. Among authors: nolan d. Lancet. 2002 Mar 2;359(9308):727-32. doi: 10.1016/s0140-6736(02)07873-x. Lancet. 2002. PMID: 11888582

2

Chronic hyperlactatemia in HIV-infected patients taking antiretroviral therapy.

John M, Moore CB, James IR, Nolan D, Upton RP, McKinnon EJ, Mallal SA. John M, et al. Among authors: nolan d. AIDS. 2001 Apr 13;15(6):717-23. doi: 10.1097/00002030-200104130-00007. AIDS. 2001. PMID: 11371686

3

HLA-B*5701 typing by sequence-specific amplification: validation and comparison with sequence-based typing.

Martin AM, Nolan D, Mallal S. Martin AM, et al. Among authors: nolan d. Tissue Antigens. 2005 Jun;65(6):571-4. doi: 10.1111/j.1399-0039.2005.00401.x. Tissue Antigens. 2005. PMID: 15896207

4

Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression.

Gaudieri S, DeSantis D, McKinnon E, Moore C, Nolan D, Witt CS, Mallal SA, Christiansen FT. Gaudieri S, et al. Among authors: nolan d. Genes Immun. 2005 Dec;6(8):683-90. doi: 10.1038/sj.gene.6364256. Genes Immun. 2005. PMID: 16121209

5

Prospective genetic screening decreases the incidence of abacavir hypersensitivity reactions in the Western Australian HIV cohort study.

Rauch A, Nolan D, Martin A, McKinnon E, Almeida C, Mallal S. Rauch A, et al. Among authors: nolan d. Clin Infect Dis. 2006 Jul 1;43(1):99-102. doi: 10.1086/504874. Epub 2006 May 26. Clin Infect Dis. 2006. PMID: 16758424 Free article.

6

HLA-B*5701 typing: evaluation of an allele-specific polymerase chain reaction melting assay.

Hammond E, Mamotte C, Nolan D, Mallal S. Hammond E, et al. Among authors: nolan d. Tissue Antigens. 2007 Jul;70(1):58-61. doi: 10.1111/j.1399-0039.2007.00840.x. Tissue Antigens. 2007. PMID: 17559582

7

Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir.

Nolan D, Upton R, McKinnon E, John M, James I, Adler B, Roff G, Vasikaran S, Mallal S. Nolan D, et al. AIDS. 2001 Jul 6;15(10):1275-80. doi: 10.1097/00002030-200107060-00009. AIDS. 2001. PMID: 11426072

8

Effects of sex and race on lipodystrophy pathogenesis.

Nolan D, Mallal S. Nolan D, et al. J HIV Ther. 2001 May;6(2):32-6. J HIV Ther. 2001. PMID: 11501201 Review. No abstract available.

9

Getting to the HAART of insulin resistance.

Nolan D, Mallal S. Nolan D, et al. AIDS. 2001 Oct 19;15(15):2037-41. doi: 10.1097/00002030-200110190-00018. AIDS. 2001. PMID: 11600834 Review. No abstract available.

10

Antiretoviral therapy and the lipodystrophy syndrome, part 2: concepts in aetiopathogenesis.

Nolan D, John M, Mallal S. Nolan D, et al. Antivir Ther. 2001 Sep;6(3):145-60. Antivir Ther. 2001. PMID: 11808750 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

641 results

Search Page

Filters